Philadelphia Inquirer (blog)Teva's Cephalon recalls 1 lot of injectable leukemia drug TreandaPhiladelphia Inquirer (blog)The drug is approved for the treatment of patients with "indolent B-cell non-Hodgkin's lymphoma (NHL) that has progres…
ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and …MarketWatch (press release)Phase II trials are now in process that evaluate SAR3419: (1) as a single agent for diffuse large B-cell lymphoma (DLBCL); (2) in combination wi…
The Zacks Analyst Blog Highlights: The Boeing, Lockheed Martin, Abbott Labs …Sacramento BeeAbbott Labs, along with partner Biogen (Nasdaq: BIIB), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple sclerosis (RRM…
The Zacks Analyst Blog Highlights: The Boeing, Lockheed Martin, Abbott Labs …NASDAQAbbott Labs, along with partner Biogen ( BIIB ), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple sclerosis ( RRMS ). Abbott L…
The Zacks Analyst Blog Highlights: The Boeing, Lockheed Martin, Abbott Labs …PR Newswire (press release)Abbott Labs, along with partner Biogen (Nasdaq: BIIB), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple s…
NICE final OK extends use of MabTheraPharma TimesThe National Institute for Health and Clinical Excellence (NICE) has issued final guidance recommending Roche's MabThera (rituximab) as an option when used in combination with a wide range of chemoth…
Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN®Business Wire (press release)Deaths have occurred within 24 hours of rituximab infusion, an essential component of the ZEVALIN therapeutic regimen. These fatalities were associated…
Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN(R)MarketWatch (press release)Deaths have occurred within 24 hours of rituximab infusion, an essential component of the ZEVALIN therapeutic regimen. These fatalities were associated …
Approval of first-ever medicine for rare blood vessels diseases offers hope …Canada NewsWire (press release)1 Today, Roche announced that RITUXAN ® (rituximab), in combination with glucocorticoids, is the first medicine approved by Health Canada for…
Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth …MarketWatch (press release)Presented New Daclizumab Data at Multiple Sclerosis Congress Announced with our partner company Biogen Idec additional results from the SELECT Phase 2…